Results 11 to 20 of about 8,581 (194)

The Therapeutic Potential of Psilocybin

open access: yesMolecules, 2021
The psychedelic effects of some plants and fungi have been known and deliberately exploited by humans for thousands of years. Fungi, particularly mushrooms, are the principal source of naturally occurring psychedelics.
Henry Lowe   +7 more
doaj   +2 more sources

Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice

open access: yesFrontiers in Pharmacology, 2023
The classical psychedelic psilocybin is of interest as a treatment for alcohol use disorder (AUD). This study investigated the effects of psilocybin on voluntary ethanol consumption in adult male and female C57BL/6J mice administered saline or psilocybin
Kenneth Alper   +9 more
doaj   +1 more source

Psilocybin-Assisted Compassion Focused Therapy for Depression

open access: yesFrontiers in Psychology, 2022
Psilocybin-assisted psychotherapy, i.e., psilocybin treatment with psychological support, has demonstrated the efficacy of psilocybin to reduce depressive symptoms.
Wendy Pots, Farid Chakhssi
doaj   +1 more source

A systematic review to assess the use of psilocybin in the treatment of headaches

open access: yesEuropean Psychiatry, 2023
Introduction Psilocybin is a naturally occurring psychedelic compound whose effects have been seen in studies for treatment of depression, anxiety and pain management.
S. Bhanot   +4 more
doaj   +1 more source

The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action

open access: yesFrontiers in Pharmacology, 2020
Serotonergic agonist psilocybin is a psychedelic with antidepressant potential. Sleep may interact with psilocybin’s antidepressant properties like other antidepressant drugs via induction of neuroplasticity. The main aim of the study was to evaluate the
Daniela Dudysová   +28 more
doaj   +1 more source

Effectiveness of Psilocybin on Depression: A Qualitative Study

open access: yes, 2021
Introduction: Psilocybin mushroom use is well documented in spiritual and religious ceremonies globally. This drug is now the most popular in Europe and the USA.
Erlam, G, Alshaikhli, H, Al-Naggar, RA
core   +1 more source

Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity

open access: yesChinese Medical Journal, 2023
. Background:. Posttraumatic stress disorder (PTSD) and depression are highly comorbid. Psilocybin exerts substantial therapeutic effects on depression by promoting neuroplasticity.
Yingjie Du   +7 more
doaj   +1 more source

Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment

open access: yesEuropean Psychiatry, 2023
Introduction Substance use disorders(SUDs) are a major health concern and current treatment interventions have proven only limited success. Despite increasing effectiveness, still about 50–60% relapse within 6–12 months after treatment [Cornelius et al.,
R. Sousa   +9 more
doaj   +1 more source

Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice

open access: yesNeuroImage, 2021
Hallucinogenic agents have been proposed as potent antidepressants; this includes the serotonin (5-HT) receptor 2A agonist psilocybin. In human subjects, psilocybin alters functional connectivity (FC) within the default-mode network (DMN), a ...
Joanes Grandjean   +7 more
doaj   +1 more source

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences

open access: yesScientific Reports, 2023
Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to highly challenging (e.g., fear, grief, and paranoia). These challenging experiences contribute to hesitancy toward psychedelic-assisted psychotherapy among health
Richard J. Zeifman   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy